PolyNovo Limited (ASX:PNV)
0.9800
-0.0500 (-4.85%)
Jul 17, 2026, 4:10 PM AEST
PolyNovo Market Cap
PolyNovo has a market cap or net worth of 677.03 million as of July 17, 2026. Its market cap has decreased by -17.99% in one year.
Market Cap
677.03M
Enterprise Value
665.95M
Revenue
139.49M
Ranking
n/a
PE Ratio
69.65
Stock Price
0.98
ChartMarket Cap Chart
Since August 23, 1999, PolyNovo's market cap has increased from 33.09M to 677.03M, an increase of 1,946.19%. That is a compound annual growth rate of 11.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 677.03M | -20.33% |
| Dec 31, 2025 | 849.74M | -39.71% |
| Dec 31, 2024 | 1.41B | 23.37% |
| Dec 29, 2023 | 1.14B | -17.80% |
| Dec 30, 2022 | 1.39B | 37.79% |
| Dec 31, 2021 | 1.01B | -60.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cochlear | 7.81B |
| 4DMedical | 1.92B |
| Imricor Medical Systems | 577.96M |
| EBR Systems | 267.38M |
| Aroa Biosurgery | 202.35M |
| EMVision Medical Devices | 150.59M |
| Saluda Medical | 129.79M |
| SomnoMed | 100.78M |